Arrowstreet Capital Limited Partnership Acquires 152,101 Shares of Hill-Rom Holdings Inc (HRC)

Arrowstreet Capital Limited Partnership raised its holdings in Hill-Rom Holdings Inc (NYSE:HRC) by 304.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 202,001 shares of the medical technology company’s stock after acquiring an additional 152,101 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.31% of Hill-Rom Holdings worth $16,081,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Independent Portfolio Consultants Inc. boosted its stake in Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after acquiring an additional 849 shares during the last quarter. Seven Eight Capital LP bought a new position in Hill-Rom Holdings in the second quarter valued at approximately $127,000. Acrospire Investment Management LLC boosted its stake in Hill-Rom Holdings by 43.4% in the second quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after acquiring an additional 600 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Hill-Rom Holdings by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock valued at $175,000 after acquiring an additional 204 shares during the last quarter. Finally, Citigroup Inc. boosted its stake in Hill-Rom Holdings by 21.1% in the second quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after acquiring an additional 433 shares during the last quarter. 82.31% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://sportsperspectives.com/2017/10/12/arrowstreet-capital-limited-partnership-acquires-152101-shares-of-hill-rom-holdings-inc-hrc.html.

A number of brokerages have issued reports on HRC. Zacks Investment Research raised shares of Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, September 26th. BidaskClub cut shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Cantor Fitzgerald assumed coverage on shares of Hill-Rom Holdings in a research report on Thursday, June 29th. They set a “neutral” rating and a $86.00 price target on the stock. Stifel Nicolaus reissued a “buy” rating and set a $84.00 price target on shares of Hill-Rom Holdings in a research report on Sunday, July 30th. Finally, Needham & Company LLC assumed coverage on shares of Hill-Rom Holdings in a research report on Thursday, June 29th. They set a “buy” rating and a $95.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Hill-Rom Holdings has a consensus rating of “Buy” and an average price target of $87.80.

Shares of Hill-Rom Holdings Inc (NYSE:HRC) traded up 0.06% during trading on Thursday, hitting $77.22. 22,400 shares of the stock were exchanged. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The stock has a market cap of $5.09 billion, a P/E ratio of 45.00 and a beta of 1.19. The firm’s 50 day moving average price is $75.49 and its 200-day moving average price is $76.08.

Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The company had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. During the same period in the prior year, the firm posted $0.81 EPS. The company’s quarterly revenue was up 5.1% on a year-over-year basis. On average, analysts predict that Hill-Rom Holdings Inc will post $3.82 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 29th. Stockholders of record on Friday, September 15th were paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend was Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is currently 41.62%.

In related news, SVP Andreas G. Frank sold 3,940 shares of the stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total transaction of $306,689.60. Following the transaction, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Andreas G. Frank sold 6,870 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at $1,293,993.48. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply